Structure and Function of 3-O-sulfation in Heparan Sulfate
Structure and Function of 3-O-sulfation in Heparan Sulfate
批准号:
8463564
负责人:
Jeffrey D Esko
金额:
$27.06万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2014-04-30
关键词:
AbbreviationsAcetylglucosamineAddressAffectAffinityAnabolismAnilineAnimal ModelAntithrombinsBindingBinding ProteinsBinding SitesBiochemical GeneticsBiologicalBiological ProcessBrainCaenorhabditis elegansCarbonChemicalsChinese Hamster Ovary CellChromatographyCouplingDevelopmentDisaccharidesDiseaseEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesEvolutionExtracellular Matrix ProteinsFamilyFinancial compensationGAG GeneGenesGlucosamineGlucuronic AcidsGlycoproteinsGlycosaminoglycansGoalsGrowth FactorHeparin LyaseHeparitin SulfateHumanHydra PolypsIduronic AcidIn VitroInorganic SulfatesInterventionIsoenzymesIsotope LabelingLabelLigand BindingLigandsMaintenanceMass Spectrum AnalysisMethodsModelingModificationMusNitrous AcidOrganismPlant ResinsPlayPolysaccharidesProductionProtein IsoformsProteinsReactionRecombinantsResearch PersonnelResistanceRoleSimplexvirusSpecificityStructureStudy modelsTechniquesTestingTissue ExtractsTissuesUnspecified or Sulfate Ion SulfatesUronic AcidsVertebratesViralWild Type MouseWorkanalytical toolchemokinecostcyclophilin Bin vivoinsightliquid chromatography mass spectrometrymembermorphogensmutantolfactory lobepublic health relevancesulfationsulfotransferasetool
中文摘要
描述(由申请人提供):硫酸乙酰肝素通过相对较短的硫酸化糖序列结合许多生长因子、趋化因子、形态发生素、细胞外基质蛋白、酶和酶抑制剂。一种相对罕见的链修饰,即在葡糖胺残基的碳-3上添加硫酸盐,在其生物合成和功能方面知之甚少。在脊椎动物中存在一个由7个葡糖胺基3-O-磺基转移酶(Hs 3st)组成的家族。虽然酶已被克隆和部分表征,很少有人知道的情况下,这些修改发生,甚至更少的是已知的内源性配体结合到硫酸乙酰肝素链,含有3-O-硫酸基团。该提议的中心假设是,Hs 3sts选择性地作用于硫酸乙酰肝素中的酶活性,从而产生内源性蛋白配体的特异性结合位点。该提案的重点是(i)方法,以结构表征3-O-硫酸乙酰肝素硫酸酯,(ii)的特异性Hs 3st-1和Hs 3st-2作为模型3-O-磺基转移酶,(iii)的发现和表征的天然配体结合Hs 3st修饰链,和(iv)检查硫酸乙酰肝素从小鼠Hs 3st-1和Hs 3st-2改变。为了实现这些目标,我们有以下具体目标:目标1:建立一种定量测定硫酸乙酰肝素中二糖和四糖亚基3-O-硫酸化的方法。目的2:使用Hs 3st-1和Hs 3st-2产生功能活性的3-O-硫酸化硫酸乙酰肝素。目的3:捕获并鉴定与3-O-硫酸化硫酸乙酰肝素结合的蛋白质配体。目的4:检测Hs 3st-1和Hs 3st-2在体内结合位点的形成。我们期望,这个项目将显着提高我们的理解,这类磺基转移酶如何影响生物过程和病理状态,并验证它们作为潜在的药物干预的目标。
英文摘要
DESCRIPTION (provided by applicant): Heparan sulfate binds many growth factors, chemokines, morphogens, extracellular matrix proteins, enzymes and enzyme inhibitors via relatively short sulfated saccharide sequences. One relatively rare modification to the chains, the addition of sulfate to carbon-3 of glucosamine residues, is poorly understood in terms of its biosynthesis and function. A family of seven glucosaminyl 3-O-sulfotransferases (Hs3st) exists in vertebrates. Although the enzymes have been cloned and partially characterized, little is known about the context in which these modifications occur and even less is known about the endogenous ligands that bind to heparan sulfate chains that contain 3-O-sulfate groups. The central hypothesis of this proposal is that the Hs3sts act selectively on subsequences in heparan sulfate and thereby generate specific binding sites for endogenous protein ligands. This proposal focuses on (i) methods to structurally characterize 3-O-sulfated heparan sulfate, (ii) the specificity of Hs3st-1 and Hs3st-2 as model 3-O-sulfotransferases, (iii) the discovery and characterization of natural ligands that bind to Hs3st modified chains, and (iv) examination of heparan sulfate derived from mice altered in Hs3st-1 and Hs3st-2. Towards these goals, we have the following specific aims: Aim 1: Develop a quantitative method for determining 3-O-sulfation of disaccharide and tetrasaccharide subunits in heparan sulfate. Aim 2: Generate functionally active 3-O-sulfated heparan sulfate using Hs3st-1 and Hs3st-2. Aim 3: Capture and identify protein ligands that bind to 3-O-sulfated heparan sulfate. Aim 4: Examine the formation of binding sites by Hs3st-1 and Hs3st-2 in vivo. We expect that this project will significantly enhance our understanding on how this class of sulfotransferases influences biological processes and pathological states, and validate them as potential targets for pharmacological intervention.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
WITHDRAWN: Glycan-based biomarkers for mucopolysaccharidoses.
撤回:基于聚糖的粘多糖病生物标志物。
DOI:
10.3233/dma-130970
发表时间:
2013
期刊:
Disease markers
影响因子:
--
作者:
[Lawrence,Roger, Brown,JillianR, Lorey,Fred, Dickson,PatriciaI, Crawford,BrettE, Esko,JeffreyD]
通讯作者:
Esko,JeffreyD
A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino)glycan biosynthesis, as evidenced by 6F-GalNAc (Ac3).
6F-GalNAc (Ac3) 证明了一种常见的糖核苷酸介导的(糖胺)聚糖生物合成抑制机制。
DOI:
10.1096/fj.14-264226
发表时间:
2015
期刊:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子:
--
作者:
[vanWijk,XanderM, Lawrence,Roger, Thijssen,VictorL, vandenBroek,SebastiaanA, Troost,Ran, vanScherpenzeel,Monique, Naidu,Natasha, Oosterhof,Arie, Griffioen,ArjanW, Lefeber,DirkJ, vanDelft,FlorisL, vanKuppevelt,ToinH]
通讯作者:
vanKuppevelt,ToinH
DOI:
10.1146/annurev-biochem-060713-035314
发表时间:
2014
期刊:
Annual review of biochemistry
影响因子:
16.6
作者:
[Xu D, Esko JD]
通讯作者:
Esko JD
UCSD Biomedical Scientist Career Development Program in Glycoscience
-
批准号:10439513
-
项目类别:
-
资助金额:$105.05万
-
财政年份:2018
-
负责人:Jeffrey D Esko
-
依托单位:
Glycosylation of the perineuronal net in Alzheimer's Disease
-
批准号:9785861
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2018
-
负责人:Jeffrey D Esko
-
依托单位:
UCSD Biomedical Scientist Career Development Program in Glycoscience
-
批准号:10197205
-
项目类别:
-
资助金额:$105.5万
-
财政年份:2018
-
负责人:Jeffrey D Esko
-
依托单位:
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome
-
批准号:10171430
-
项目类别:
-
资助金额:$47.34万
-
财政年份:2016
-
负责人:Jeffrey D Esko
-
依托单位:
Project 3: Heparan Sulfate Proteoglycans in the Pathogenesis of Sepsis
-
批准号:9072755
-
项目类别:
-
资助金额:$54.16万
-
财政年份:2016
-
负责人:Jeffrey D Esko
-
依托单位:
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome
-
批准号:10641853
-
项目类别:
-
资助金额:$46.34万
-
财政年份:2016
-
负责人:Jeffrey D Esko
-
依托单位:
PROJECT 3 - Infection-Induced Remodeling of the Vascular Proteome
-
批准号:10475614
-
项目类别:
-
资助金额:$46.34万
-
财政年份:2016
-
负责人:Jeffrey D Esko
-
依托单位:
Genome-wide Analysis of Heparan Sulfate using CRISPR/Cas9
-
批准号:9103016
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2015
-
负责人:Jeffrey D Esko
-
依托单位:
Drug Discovery for Multiple Hereditary Exostoses
-
批准号:8912269
-
项目类别:
-
资助金额:$39.79万
-
财政年份:2013
-
负责人:Jeffrey D Esko
-
依托单位:
Drug Discovery for Multiple Hereditary Exostoses
-
批准号:8735612
-
项目类别:
-
资助金额:$37.7万
-
财政年份:2013
-
负责人:Jeffrey D Esko
-
依托单位:
Drug Discovery for Multiple Hereditary Exostoses
-
批准号:8630072
-
项目类别:
-
资助金额:$44.34万
-
财政年份:2013
-
负责人:Jeffrey D Esko
-
依托单位:
Drug Discovery for Multiple Hereditary Exostoses
-
批准号:9335653
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2013
-
负责人:Jeffrey D Esko
-
依托单位:
Drug Discovery for Multiple Hereditary Exostoses
-
批准号:9120805
-
项目类别:
-
资助金额:$29.21万
-
财政年份:2013
-
负责人:Jeffrey D Esko
-
依托单位:
Drug Discovery for Multiple Hereditary Exostoses
-
批准号:9283197
-
项目类别:
-
资助金额:$5.32万
-
财政年份:2013
-
负责人:Jeffrey D Esko
-
依托单位:
Mechanisms of Prion Aggregation
-
批准号:10407462
-
项目类别:
-
资助金额:$50.16万
-
财政年份:2011
-
负责人:Jeffrey D Esko
-
依托单位:
Mechanisms of Prion Aggregation
-
批准号:10626014
-
项目类别:
-
资助金额:$48.07万
-
财政年份:2011
-
负责人:Jeffrey D Esko
-
依托单位:
Gene Discovery and Heparan Sulfate Biogenesis
-
批准号:8035999
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2010
-
负责人:Jeffrey D Esko
-
依托单位:
Structure and Function of 3-O-sulfation in Heparan Sulfate
-
批准号:8260852
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2010
-
负责人:Jeffrey D Esko
-
依托单位:
Structure and Function of 3-O-sulfation in Heparan Sulfate
-
批准号:7863947
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2010
-
负责人:Jeffrey D Esko
-
依托单位:
Gene Discovery and Heparan Sulfate Biogenesis
-
批准号:7772485
-
项目类别:
-
资助金额:$23.79万
-
财政年份:2010
-
负责人:Jeffrey D Esko
-
依托单位:
海外基金